BamSEC and AlphaSense Join Forces
Learn More

Poseida Therapeutics Inc.

NASDAQ: PSTX    
Share price (12/20/24): $9.45    
Market cap (12/20/24): $921 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.2
from 8-K 25 pages Amended and Restated Bylaws of Poseida Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 6 pages Amended and Restated Certificate of Incorporation of Poseida Therapeutics, Inc
12/34/56
EX-3.4
from S-1/A 25 pages Amended and Restated Bylaws of Poseida Therapeutics, Inc
12/34/56
EX-3.2
from S-1/A 6 pages Amended and Restated Certificate of Incorporation of Poseida Therapeutics, Inc
12/34/56
EX-3.1
from S-1/A 29 pages Amended and Restated Certificate of Incorporation of Poseida Therapeutics, Inc
12/34/56
EX-3.3
from S-1 26 pages Corporate Seal
12/34/56
EX-3.1
from S-1 27 pages Amended and Restated Certificate of Incorporation of Poseida Therapeutics, Inc
12/34/56
EX-3.3
from DRS 26 pages Corporate Seal
12/34/56
EX-3.1
from DRS 27 pages Amended and Restated Certificate of Incorporation of Poseida Therapeutics, Inc
12/34/56
EX-3.4
from S-1/A 25 pages Amended and Restated Bylaws of Poseida Therapeutics, Inc
12/34/56
EX-3.2
from S-1/A 6 pages Amended and Restated Certificate of Incorporation of Poseida Therapeutics, Inc
12/34/56
EX-3.4
from S-1 25 pages Amended and Restated Bylaws of Poseida Therapeutics, Inc
12/34/56
EX-3.3
from S-1 26 pages Corporate Seal
12/34/56
EX-3.2
from S-1 6 pages Amended and Restated Certificate of Incorporation of Poseida Therapeutics, Inc
12/34/56
EX-3.1
from S-1 31 pages Amended and Restated Certificate of Incorporation of Poseida Therapeutics, Inc
12/34/56
EX-3.3
from DRS 26 pages Corporate Seal
12/34/56
EX-3.1
from DRS 29 pages Amended and Restated Certificate of Incorporation of Poseida Therapeutics, Inc
12/34/56